Second Line Chemotherapy with Docetaxel in Patients with Recurrent Malignant Glioma: A Phase II Study
- 1 January 2000
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 50 (3) , 245-249
- https://doi.org/10.1023/a:1006494032052
Abstract
The objective of the study was to assess the efficacy of docetaxel in recurrent supratentorial malignant gliomas. The sample size of the study was determined by the Gehan's method for a response rate...Keywords
This publication has 16 references indexed in Scilit:
- Single-agent docetaxel (Taxotere) in randomized phase III trials.1999
- Salvage Chemotherapy with Taxol for Recurrent Anaplastic AstrocytomasJournal of Neuro-Oncology, 1999
- Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas.Journal of Clinical Oncology, 1997
- Docetaxel.Journal of Clinical Oncology, 1995
- Salvage chemotherapy with paclitaxel for recurrent primary brain tumors.Journal of Clinical Oncology, 1995
- Paclitaxel Disposition in Plasma and Central Nervous Systems of Humans and Rats With Brain TumorsJNCI Journal of the National Cancer Institute, 1995
- Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.1994
- Cytotoxicity of taxol in vitro against human and rat malignant brain tumorsCancer Chemotherapy and Pharmacology, 1994
- Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.1991
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990